DURHAM, NC– – Aldagen, Inc. today announced that a poster describing the homing properties of its cellular therapies was presented at the Seventh International Conference on Cell Therapy for Cardiovascular …
Visit link:
Aldagen Presents Data Describing Cell Therapy Products' Mechanism for Homing to Ischemic Injury
Officials at the Texas Heart Institute at St. Luke’s Episcopal Hospital announced today that Doris Taylor, PhD, FAHA, FACC, one of the world’s leading cell thera
See more here:
World-Renowned Cell-Therapy Researcher, Doris Taylor, PhD, Joins Texas Heart Institute at St. Luke’s Episcopal Hospital
TORONTO – Doctors have performed Ontario's first cardiac stem cell transplant using cells from the patient's own bone marrow.
View original post here:
Researchers hope cardiac stem cell transplants may help heart failure patients
Heart failure is a leading cause of death in Canada. As part of the ongoing IMPACT-CABG clinical trial to treat advanced heart failure, physicians at the Peter Munk Cardiac Centre performed the first cardiac stem cell transplant in Ontario last week using stem cells derived from the patient's own bone marrow, isolated completely within the operating room, and implanted into the heart at the time …
Visit link:
Ontario's first cardiac stem cell transplant performed last week
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced interim results from 32 patients treated to date in a phase I clinical trial of ADCETRIS administered in combination with or sequentially with chemotherapy for the treatment of newly diagnosed systemic anaplastic large cell lymphoma and other CD30-positive mature T-cell lymphoma patients.
View original post here:
Seattle Genetics and Millennium Report Data from Phase I Trial of ADCETRIS™ in Front-line Mature T-Cell Lymphomas
SAN FRANCISCO–(BUSINESS WIRE)– Seattle Genetics , Inc.
See the original post:
Seattle Genetics Announces Data from ADCETRIS™ in Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma
26-10-2011 07:18 Genetic engineering may be one of the greatest breakthroughs in recent history, however, with scientific advancements new ethical issues are raised, forcing us to ask not how, but if we should push genetic research to its absolute limit. This programme looks at the possible benefits of genetic engineering, such as the curing of hereditary diseases and the creation of better, more efficient crops
Read the original:
Genetic Engineering (excerpt) – Video
Research and Markets has announced the addition of the “Medical Nanotechnology Market Guide 2012″ report to t
Originally posted here:
Research and Markets: Medical Nanotechnology Market Guide 2012
Celator Pharmaceuticals today announced that the European Commission has granted orphan drug status to CPX-351, the company’s proprietary “liposomal combination of cytarabine and daunorubicin,” for the treatment of acute myeloid leukemia .
Continue reading here:
Celator® Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia
22-12-2011 08:22 Joseph Buxbaum discusses the influence of genetics on autism spectrum disorders.
Read the original here:
Genetics of Autism Spectrum Disorders: From Genes to Novel Therapeutics – Video
Stem cell research, while controversial, has always been touted as the future of disease treatment. There's more evidence to support that claim, as it turns out that stem cell treatment can help cure blindness
See the original post here:
Stem Cell Treatment For Blindness Works, and Is Safe [Medicine]
20-01-2012 17:36 Dr. James Wilson is a professor in the department of pathology and laboratory medicine, and the director of the gene therapy program, at the University of Pennsylvania. He is also the editor of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc
Continued here:
James Wilson, MD, Ph.D., on Gene Therapy as a Disruptive Technology – Video
LA JOLLA, Calif., Jan. 25, 2012 /PRNewswire/ – Interest in adult stem cell therapies and their clinical applicability in treating and helping patients is growing, while accurate information remains difficult …
Go here to see the original:
Cell Society International Hosts its 2nd Annual Clinical Conference in San Diego, CA, to Discuss Clinical Advancements …
Allan Wu, MD, co-founder and chief scientific officer of The Morrow Institute’s Non-Controversial Stem Cell Research Lab in Rancho Mirage, CA, has been invited to present his research findings at Stem Cells 2012, a global conference in San Diego, CA.
View post:
Morrow Institute’s Allan Wu, MD, to Present at Stem Cells 2012 Conference
COLUMBIA, Md., Jan. 25, 2012 /PRNewswire/ – The Maryland Stem Cell Research Commission (Commission) has announced a new program for pre-clinical and clinical research grants. This program will support …
See the original post here:
Maryland Stem Cell Research Commission Announces New Program for Pre-Clinical and Clinical Research Grants
Robert Lanza, chief scientific officer of Advanced Cell Technology. Advanced Cell Technology Eye Study Is a Small but Crucial Advance for Stem-Cell Therapy The results show that the treatment can be safe, but whether it can be effective is another question
More:
Eye Study Is a Small but Crucial Advance for Stem-Cell Therapy
WESTMINSTER, Colo., Jan. 25, 2012 /PRNewswire/ — GeneThera, Inc.
Originally posted here:
GeneThera, Inc. Acquires Applied Genetics, S.A.
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today the dosing of an additional patient in its Phase 1/2 trial for Stargardt’s macular dystrophy using retinal pigment epithelial cells derived from human embryonic stem cells .
Go here to read the rest:
ACT Announces that Additional Patient with Stargardt’s Disease Has Undergone Embryonic Stem Cell Transplantation at …
Genethon relaunches itself as a force for translational medicine.
Continued here:
French institute prepares for gene-therapy push